Impact of artificial intelligence in vision science: A systematic review of progress, emerging trends, data domain quantification, and critical gaps.
Lewallen Colby F, Ortolan Davide, Reichert Dominik, Sharma Ruchi, Bharti Kapil
AI Summary
This study found AI in vision science is heavily focused on image analysis, particularly for AMD/DR, but lags in cataract research, highlighting data and ethical challenges for broader clinical integration.
Abstract
The prominence of artificial intelligence (AI) is growing exponentially, yet its implementation across research domains is uneven. To quantify AI trends in vision science, we evaluated over 100,000 PubMed article metadata spanning 35 years. Using Medical Subject Headings (MeSH) terms, we analyzed trends across four prominent ocular diseases: age-related macular degeneration, diabetic retinopathy, glaucoma, and cataract. Most articles utilized research techniques from at least one of the following domains: biological models, molecular profiling, image-based analysis, and clinical outcomes. Our quantification reveals that AI prominence is disproportionally concentrated in the image-based analysis domain, and, additionally, among 4 diseases evaluated, AI prevalence in cataract research is lagging. Contributing factors towards these disparities include insufficient data standardization, complex data structures, limited data availability, unresolved ethical concerns, and not gaining meaningful improvements over human-based interpretations. By mapping where AI thrives and where it lags, we offer a quantitative reference for funding agencies, clinicians, and vision scientists. Connecting various research domains with multimodal and generative AI could improve diagnostic utility; enabling earlier diagnosis, personalized therapy, reduced healthcare costs, and accelerate innovation. Future work should move AI in vision science beyond image-centric pattern recognition toward integrative, mechanistic analyses that explain - rather than merely detect - disease.
MeSH Terms
Shields Classification
Key Concepts5
Artificial intelligence (AI) prominence is disproportionally concentrated in the image-based analysis domain within vision science research.
Among four prominent ocular diseases (age-related macular degeneration, diabetic retinopathy, glaucoma, and cataract), AI prevalence in cataract research is lagging.
Contributing factors to disparities in AI implementation across vision science research domains include insufficient data standardization, complex data structures, limited data availability, unresolved ethical concerns, and not gaining meaningful improvements over human-based interpretations.
Connecting various research domains with multimodal and generative AI could improve diagnostic utility, enabling earlier diagnosis, personalized therapy, reduced healthcare costs, and accelerated innovation in vision science.
Future work in AI in vision science should move beyond image-centric pattern recognition toward integrative, mechanistic analyses that explain disease rather than merely detect it.
Related Articles5
Artificial Intelligence and Ophthalmic Clinical Registries.
Systematic ReviewDiagnosing glaucoma in primary eye care and the role of Artificial Intelligence applications for reducing the prevalence of undetected glaucoma in Australia.
ReviewScreening of Glaucoma: Consensus and Directions.
ReviewEvaluation of an offline, artificial intelligence system for referable glaucoma screening using a smartphone-based fundus camera: a prospective study.
Prospective StudyBarriers and Potential Solutions to Glaucoma Screening in the Developing World: A Review.
ReviewIs this article assigned to the wrong chapter(s)? Let us know.